Natalie Len
Psychiatric/Mental Health · Oldsmar, FLNPI 1013629047
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 621 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 22.0% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 621 payments — averaging $23.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Otsuka America Pharmaceutical, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Teva Pharmaceuticals USA, Inc.$991
- Johnson & Johnson$774
- Neuronetics, Inc.$755
- plus $7K from 25 others
What the payments were for
- Food & beverage$14,681100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 127 | $3,233 |
| Otsuka America Pharmaceutical, Inc. | 55 | $1,429 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 42 | $1,003 |
| Teva Pharmaceuticals USA, Inc. | 30 | $991 |
| Johnson & Johnson | 30 | $774 |
| Neuronetics, Inc. | 8 | $755 |
| Alkermes, Inc. | 26 | $736 |
| Takeda Pharmaceuticals U.S.A., Inc. | 25 | $583 |
| Neurocrine Biosciences, Inc. | 29 | $583 |
| Axsome Therapeutics, Inc. | 15 | $571 |
| Noven Therapeutics, LLC | 32 | $478 |
| Lundbeck LLC | 20 | $468 |
| Corium, LLC | 20 | $414 |
| Supernus Pharmaceuticals, Inc. | 39 | $413 |
| Vanda Pharmaceuticals Inc. | 20 | $389 |
| Tris Pharma Inc | 25 | $389 |
| Almatica Pharma LLC | 15 | $285 |
| Neos Therapeutics, LP | 22 | $266 |
| Bausch Health US, LLC | 9 | $187 |
| Idorsia Pharmaceuticals US Inc | 7 | $140 |
| Ironshore Pharmaceuticals Inc. | 6 | $135 |
| Collegium Pharmaceutical, Inc. | 5 | $104 |
| Validus Pharmaceuticals LLC | 2 | $104 |
| Sage Therapeutics, LLC | 3 | $63 |
| E.r. Squibb & Sons, L.L.C. | 2 | $50 |
| Indivior Inc. | 2 | $42 |
| OWP Pharmaceuticals, Inc. | 1 | $25 |
| Noven Pharmaceuticals, Inc. | 1 | $23 |
| Harmony Biosciences LLC | 1 | $22 |
| Vertical Pharmaceuticals, LLC | 1 | $17 |
| Avion Pharmaceuticals | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$760
- NEUROSTAR TMS THERAPY SYSTEM$640
- LYBALVI$449
- ARISTADA$417
- UZEDY$337
- Auvelity$251
- REXULTI$250
- CAPLYTA$240
- ABILIFY ASIMTUFII$124
- ABILIFY MAINTENA$124
- SPRAVATO$121
- AUSTEDO$118
- ARISTADA INITIO$104
How this compares
$14,689 in reported general payments places this provider in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 18 | $644 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Oldsmar
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
- Natalie MoodyWinter Haven$75K
- Kelli BridgmanNew Smyrna Beach$66K
- Carolann BrooksCelebration$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.